FeesSafety
Pluang+

GMX's Solana platform hits $25B trading volume in October, leading Solana's decentralized perpetual exchanges.

Protocol Fundamentals
03 Nov 2026, 14:48 WIB
Tokenpost
View Source
Bullish
GMX's Solana platform hits $25B trading volume in October, leading Solana's decentralized perpetual exchanges.

GMX's decentralized trading platform on Solana, gmtrade_xyz, achieved a record $25 billion in trading volume in October, marking its highest monthly volume since June. This volume surpassed that of other perpetual decentralized exchanges on the Solana blockchain. GMX specializes in leveraged perpetual contracts and recently introduced Builder Fees, allowing third-party developers to earn fees from position orders routed through their tools. This growth highlights GMX's expanding influence in the decentralized trading space on Solana.

GMX's Solana trading platform reached $25 billion in trading volume in October. For readers following the broader cryptocurrency market, 12 of 50 major cryptocurrencies on Pluang rose while 37 fell as of Nov 03, 2026 19:03 WIB. Notable movers include EOS with a price of Rp12.649 and a 1-day change of +8.13%, CRV down 5.07%, and BAT down 4.09%.

More News

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

The global Automatic FOUP Opener Market is projected to grow from USD 4.41 billion in 2026 to USD 6.04 billion by 2032, expanding at a CAGR of 5.36%. Growth is driven by increasing fab automation, stricter contamination control requirements, and dema...

Market News
Bullish
20 minutes ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
3 hours ago
Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
3 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
3 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App